Clinical Trial Details
| Trial ID: | L2890 |
| Source ID: | NCT00698789 |
| Associated Drug: | Incb019602 |
| Title: | Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: INCB019602|DRUG: INCB019602|DRUG: INCB019602|DRUG: INCB019602|DRUG: INCB019602|DRUG: Placebo|DRUG: Metformin |
| Outcome Measures: | Primary: Safety and tolerability as determined by monitoring of AEs, vital signs, ECGs, physical examinations, and clinical laboratory blood and urine parameters., End of Study | Secondary: Change from Baseline in fasting plasma glucose and population pharmacokinetics of INCB019602 in type 2 diabetic patients., End of Study |
| Sponsor/Collaborators: | Sponsor: Incyte Corporation |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 48 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2008-05 |
| Completion Date: | 2009-06 |
| Results First Posted: | |
| Last Update Posted: | 2012-10-30 |
| Locations: | Phoenix, Arizona, 85029, United States|Tucson, Arizona, 85705, United States|Chula Vista, California, 91911, United States|Los Angeles, California, United States|Mission Viejo, California, 92691, United States|Orange, California, 92869, United States|Paramount, California, 90723, United States|San Diego, California, 92117, United States|Santa Ana, California, 92701, United States|Tustin, California, 92780, United States|Colorado Springs, Colorado, 80909, United States|St. Petersburg, Florida, 33709, United States|Shawnee Mission, Kansas, 66216, United States|Shreveport, Louisiana, 71101, United States|Dearborn, Michigan, 48126, United States|St. Louis, Missouri, 63110, United States|Omaha, Nebraska, 68154, United States|Elizabeth, New Jersey, 07202, United States|Charlotte, North Carolina, 28211, United States|Oklahoma City, Oklahoma, 73103, United States|East Providence, Rhode Island, 02914, United States|San Antonio, Texas, 78229, United States |
| URL: | https://clinicaltrials.gov/show/NCT00698789 |
